Eric Lawrence, DO
Family Medicine · Casper, WYNPI 1326223751
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 379 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in WY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 379 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- AbbVie$964
- Lilly USA, LLC$740
- Novo Nordisk$652
- GSK$604
- Merck$441
- plus $2K from 37 others
What the payments were for
- Food & beverage$7,02999%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 75 | $1,500 |
| AbbVie(2 entities) | 41 | $964 |
| Lilly USA, LLC | 45 | $740 |
| Novo Nordisk | 31 | $652 |
| GSK | 39 | $604 |
| Merck | 25 | $441 |
| Otsuka America Pharmaceutical, Inc. | 18 | $247 |
| Amgen(2 entities) | 13 | $235 |
| Sanofi-aventis U.S. LLC | 11 | $182 |
| Bayer | 10 | $176 |
| Pfizer | 7 | $173 |
| Lundbeck LLC | 4 | $89 |
| Teva Pharmaceuticals USA, Inc. | 1 | $78 |
| Novartis | 4 | $78 |
| Corium, LLC | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $59 |
| Exact Sciences | 3 | $58 |
| Boston Scientific | 3 | $55 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
| Idorsia Pharmaceuticals US Inc | 3 | $50 |
| Eisai Inc. | 3 | $49 |
| Boehringer Ingelheim | 3 | $47 |
| Abbott | 3 | $43 |
| Viatris Specialty LLC | 2 | $42 |
| Mylan Specialty L.p. | 2 | $37 |
| Bristol Myers Squibb | 2 | $34 |
| Neurelis, Inc. | 2 | $34 |
| Biogen | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Corcept Therapeutics | 1 | $21 |
| UCB, Inc. | 1 | $20 |
| Sonex Health, Inc. | 1 | $19 |
| Abiomed | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Organon | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Optinose US, Inc. | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Philips North America LLC | 1 | $12 |
| Ultragenyx Pharmaceutical Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$108
How this compares
$7,073 in reported general payments places this provider in the 95th percentile of 237 family medicine providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 570 | $212,272 |
| OzempicSemaglutide | 77 | $90,824 |
| MounjaroTirzepatide | 52 | $54,621 |
| TrulicityDulaglutide | 56 | $53,091 |
| OtezlaApremilast | 19 | $49,078 |
| RexultiBrexpiprazole | 58 | $47,963 |
| FanaptIloperidone | 13 | $45,814 |
| Invega SustennaPaliperidone Palmitate | 12 | $43,962 |
| XareltoRivaroxaban | 77 | $43,933 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 42 | $40,544 |
| FarxigaDapagliflozin Propanediol | 47 | $28,580 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 32 | $27,969 |
| NuplazidPimavanserin Tartrate | 11 | $27,025 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 39 | $24,098 |
| LinzessLinaclotide | 40 | $21,350 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Premarin | $173 | $218,634584 claims |
| Lilly USA, LLCMounjaro, Trulicity | $740 | $107,712108 claims |
| Novo NordiskOzempic | $652 | $90,82477 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,500 | $52,67986 claims |
| AmgenOtezla | $235 | $49,07819 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $604 | $48,23757 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $247 | $47,96358 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $17 | $45,81413 claims |
| MerckJanumet Xr, Dulera | $441 | $34,53044 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $47 | $25,70770 claims |
| AbbVieLinzess | $964 | $21,35040 claims |
| Aimmune Therapeutics, Inc.Zenpep | $18 | $6,78112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 237 family medicine providers in Wyoming.
Other family medicine in Casper
- Joseph SchoeberCasper$176K
- James McLennanCasper$13K
- Karlynn SieversCasper$10K
- Louis RoussalisCasper$5K
- Joseph MickelsonCasper$5K
- Jonathan BinderCasper$4K
- Sherrill FoxCasper$4K
- Taylor PedersenCasper$4K
- Tiffany SpauldingCasper$2K
- Brehan NewellCasper$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.